Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the antiviral efficacy of a quadruple drug regimen (VX-222, telaprevir, Peg-IFN and RBV) in subjects with genotype 1 CHC with compensated cirrhosis, who are treatment naive or were nonresponders (partial or null) or relapsers to previous Peg-IFN/RBV therapy.
Critère d'inclusion
- Chronic Hepatitis C Virus